In the US, Sugammadex (sugammadex systemic) is a member of the drug class miscellaneous central nervous system agents and is used to treat Reversal of Neuromuscular Blockade and Reversal of Nondepolarizing Muscle Relaxants.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Cyclooctakis-(1->4)-[6-S-(2-carboxyetyl)-6-tio-α-D-glucopyranosyl] (IUPAC, WHO)
- Sugammadexum (Latin)
- Sugammadex (German)
- Sugammadex (French)
- Sugammadex (Spanish)
- Sugammadex (OS: BAN)
- Sugammadex Sodium (OS: USAN, JAN, BANM)
- Org 25969 (IS)
Merck, Iceland; Merck Sharp & Dohme, Cyprus; Merck Sharp & Dohme, Philippines; Merck Sharp & Dohme, Romania; MSD, Thailand; MSD Argentina, Argentina; MSD Merck Sharp & Dohme, Turkey; MSD Polska, Poland; Organon, Georgia; Organon, Israel; Organon, Peru; Organon, Slovakia; Organon, Tunisia; Schering-Plough, Ecuador; Merck Sharp & Dohme Asia, Vietnam
- Bridion 100 mg/ml
MSD Pharma, Hungary
Merck, Brazil; Merck Canada, Canada; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Chile; Merck Sharp & Dohme, Spain; Merck Sharp & Dohme, United Kingdom; Merck Sharp & Dohme, Greece; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Lithuania; Merck Sharp & Dohme, Malaysia; Merck Sharp & Dohme, Netherlands; Merck Sharp & Dohme, New Zealand; Merck Sharp & Dohme, Slovenia; MSD, Costa Rica; MSD, Czech Republic; MSD, Denmark; MSD, Dominican Republic; MSD, Finland; MSD, France; MSD, Guatemala; MSD, Honduras; MSD, Ireland; MSD, Japan; MSD, Nicaragua; MSD, Norway; MSD, Panama; MSD, Sweden; MSD, El Salvador; MSD Belgium, Belgium; MSD Belgium, Luxembourg; N.V. Organon, Macedonia; N.V. Organon, Serbia; Organon, United States
- Bridion 100 mg/ml
Grünenthal, Germany; Merck Sharp & Dohme, Austria
- Bridion 200mg/2ml
- Bridion 500mg/5ml
|BAN||British Approved Name|
|BANM||British Approved Name (Modified)|
|JAN||Japanese Accepted Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.